CWLXFOTCMedicinal Chemicals & Botanical ProductsUS GAAP · USD

C21 Investments Inc.

C21 Investments Inc. is a vertically integrated cannabis company based in Vancouver, Canada that operates primarily in Nevada through wholly owned U.S. subsidiaries. It cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products through retail and wholesale channels, with brand assets that include Silver State Relief, Silver State Cultivation, Phantom Farms, Hood Oil, and Eco Firma Farms.

Revenue32.6m USD
+8.3 %y/y
Operating profit (EBIT)2.3m USD
+77.8 %y/y
EBIT margin7.0%
+2.7 ppy/y
Net income-3.2m USD
+18.3 %y/y

Fiscal year 2026 · change from previous year

Development 2021–2026

010203040m USD2021: 33 m USD2021: EBIT 9.2 m USD20212022: 33 m USD2022: EBIT 9.8 m USD20222023: 29 m USD2023: EBIT 4.0 m USD20232024: 4.5 m USD2024: EBIT 0.29 m USD20242025: 30 m USD2025: EBIT 1.3 m USD20252026: 33 m USD2026: EBIT 2.3 m USD2026332.3
RevenueOperating profit (EBIT)

Business

Share of revenue
Cultivation35 %

Indoor/outdoor cannabis growing and harvest of flower and biomass.

Retail dispensary sales30 %

Direct-to-consumer sales of cannabis and hemp-derived products in Nevada.

Processing and manufacturing15 %

Conversion of plant material into oils, cartridges, edibles and other formats.

Wholesale distribution15 %

Sale of branded cannabis products to third-party dispensaries and channels.

Brand portfolio and CPG5 %

THC and CBD consumer products sold under legacy Nevada and Oregon brands.

Customers

C21 sells primarily to adult-use and medical cannabis consumers in Nevada through its owned retail locations. It also serves wholesale buyers and retail partners that purchase branded flower, oils, pre-rolls, vape products, edibles, tinctures, and topicals for resale. The company’s brands are positioned for customers seeking locally produced cannabis products with a mix of store-based selection and branded packaged goods.

Nevada retail consumers

Buy cannabis and hemp-derived products directly from C21 dispensaries for convenience and brand selection.

Wholesale dispensaries and retailers

Purchase branded flower, oils, cartridges, and packaged products for resale.

Medical cannabis patients

Buy products used for symptom relief and ongoing therapeutic use where allowed.

Adult-use consumers

Purchase recreational cannabis formats such as flower, pre-rolls, edibles, and vapes.

Strategy

C21’s strategy is centered on vertically integrated control of cannabis production, manufacturing, and retail in Nevada. It emphasizes acquiring and integrating assets that can immediately contribute to the platform, while expanding branded consumer products through captive retail and wholesale channels. The business also focuses on retail execution and disciplined use of existing brands to extend its product reach.

Vertical integration in NevadaMedium term

Owning more of the supply chain helps control product quality, supply, and channel economics.

Branded product expansionMedium term

Consumer brands can scale across captive retail and wholesale channels.

Retail execution and footprint developmentShort term

Retail locations provide direct customer access and support higher-margin brand visibility.

Geography

C21’s operating footprint is concentrated in Nevada, where it spans cultivation, processing, distribution, and retail licensing across the cannabis supply chain. The company is headquartered in Vancouver, Canada, but its business activity and revenue generation are primarily U.S.-based through Nevada subsidiaries. Legacy brands from Oregon add product identity and support branded sales, but the core operating market remains Nevada.

Risks

C21 is exposed to state cannabis regulation, licensing, and enforcement risk because its operations depend on Nevada licenses and compliance across the supply chain. The business is also sensitive to pricing pressure, excise taxes, and competition in retail and wholesale cannabis, while its small geographic concentration increases exposure to any adverse change in Nevada demand or rules. Accounting judgment is material because cannabis inventory, long-lived assets, and goodwill can be impacted by impairment and fair-value estimates.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Cannabis regulatory and licensing risk1Geographic concentration in Nevada2Competitive pricing pressure3Inventory and asset impairment4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Cannabis regulatory and licensing riskImpact: HighLikelihood: High

    Operations depend on state licenses and evolving cannabis rules in Nevada.

    Exposure: Nevada supply chain and retail licenses

  2. Geographic concentration in NevadaImpact: HighLikelihood: High

    Most business activity is in one state, limiting diversification.

    Exposure: Single-state operations

  3. Competitive pricing pressureImpact: MediumLikelihood: High

    Cannabis retail and wholesale markets can be fragmented and price-sensitive.

    ExposureFlowerVapesEdiblesWholesale channels
  4. Inventory and asset impairmentImpact: MediumLikelihood: Medium

    Cannabis inventory, retail assets, and goodwill require periodic recoverability testing.

    ExposureCultivationManufacturingRetail assets

Accounting

Judgemental items
Inventory valuation

Cannabis inventory must be measured against net realizable value and can be written down if prices fall or product ages.

Impact: Can affect gross margin and asset carrying values

Goodwill impairment

The Nevada reporting unit’s goodwill must be tested for recoverability and may be written down if value falls.

Impact: Can create large non-cash charges

Long-lived asset impairment

Retail, cultivation and processing assets are tested when indicators of impairment arise.

Impact: Can reduce property, equipment and intangible asset balances

Share-based compensation

Equity awards are measured at grant-date fair value and expensed over vesting periods.

Impact: Affects operating expenses and equity

Derivative liability fair value

Derivative instruments require periodic remeasurement using assumptions and market inputs.

Impact: Can create earnings volatility

Publicly listed companies with a comparable business focus.

Last updated: 28/09/2026